Skip to main content
. 2020 Nov 25;22:129. doi: 10.1186/s13058-020-01365-9

Fig. 1.

Fig. 1

Associations between estrogen-alone therapy (ET) at baseline and risk of breast cancer, by estrogen and progesterone receptor status and histology type, among eligible postmenopausal women with hysterectomy (n = 50,476) in the entire National Institutes of Health-AARP Diet and Health Study cohort (1996/1997–2011). BC, breast cancer. ER, estrogen receptor. PR, progesterone receptor